Were they writing about global trade? did this include the ASX co.s? Here we have quite a relatively small sector with fairly good differentiation. Also SPs generally are rising, even ELX has risen from its low of 51c to $1.06, with a 10.5c rise just today.
The Aus cannabis sector has had some of the regulatory inhibitions lifted over the last 6 months with Greg Hunt finally bowing to corp and health pressure to allow greater access to prescription services. There is a medical centre chain (5 centres) launching its IPO, possibly next month (Im interested). More medical practitioners are being accredited as CBN prescribers.
AC8 has a unique access to the market with the hard shell caps, This will boost the bioavailability of CBN and increase shelf life and reduce storage issues. The SP has risen 16.5c to 35.5c in the last month.
IMO the Morgans report may not have included ASX co.s as our sector and our market is so small. yet IMO most ASX co.s are rising from around similar times by around similar doubling of values and ASX co.s are showing considerable evidence of beginning to achieve the potential tipping point of growth.
AC8 Price at posting:
36.0¢ Sentiment: Buy Disclosure: Held
(20min delay)